During the past decade, The Adam Practice conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Adam Practice" #1 sponsor was "Abbott Nutrition" with 2 trials, followed by "Amgen" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company" with 1 trials sponsored and "Firstkind Ltd" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Adam Practice" #1 collaborator was "BHR Limited" with 1 trials as a collaborator, "Cambridge University Hospitals NHS Foundation Trust" with 1 trials as a collaborator, "Clinical Trials Unit, Manchester" with 1 trials as a collaborator, "Diabetes UK" with 1 trials as a collaborator and "East Suffolk and North Essex NHS Foundation Trust" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "The Adam Practice" are "Atherosclerotic Cardiovascular Disease" (2 trials), "Cardiovascular Diseases" (1 trials), "Coronary Heart Disease (CHD)" (1 trials), "Diabetes Mellitus, Type 1" (1 trials) and "Dyslipidemic" (1 trials). Many other conditions were trialed in "The Adam Practice" in a lesser frequency.

Most popular intervention types in "The Adam Practice" are "Other" (5 trials), "Drug" (3 trials), "Device" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Amino Acid-Based Experimental Study Formula" (1 trials), "Evolocumab" (1 trials), "ExPEC9V" (1 trials) and "Free Style Libre 2" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Adam Practice" are 10 trials for "All" genders.

Currently, there are NaN active trials in "The Adam Practice". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in The Adam Practice, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in The Adam Practice, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".